Yahoo Web Search

Search results

    • Beyond BCMA-Directed CAR T-Cell Therapy

      MedPage Today· 1 day ago

      Although survival rates for patients with multiple myeloma are improving, with a 5-year rate of about 60%, many patients relapse after treatment. "Patients have seen impressive advances in survival ...